Allergic rhinitis: approaches to diagnostics and management
A.A. Chotchaeva¹, A.I. Kolotilina¹, I.A. Korsunskiy^1,2, G.I. Smirnova¹, A.I. Asmanov³, D.B. Munblit<sup>1

1</sup> Sechenov University, Moscow
² Dmitry Rogachev National Research Center of Paediatric Hematology, Oncology and Immunology, Moscow
³ Pirogov Russian National Research Medical University, Moscow

Allergic rhinitis (AR) is one of the most common chronic conditions in children, however, it is still frequently underdiagnosed and undertreated. AR is not a life-threatening condition but lack of good control over AR symptoms results in a significant decrease in quality of life and affects school performance and work. AR is considered the most important risk factor for asthma development.
AR diagnostics are built around clinical history and allergy testing. The AR therapy is based on the use of intranasal corticosteroids and second-generation antihistamines. Both drug groups are highly effective and have good safety profile. First-generation antihistamines, in contrast, have a significant sedative effect, associated with reduced academic performance, and should not be routinely used in AR patients. Specific immunotherapy is highly effective in patients with well-established cause of symptoms.
Importance of standartised, evidenced-based approach to AR diagnosis and management is highlighted in both National and International guidelines. This review considers the current approaches to diagnosis and management of AR.

Key words: allergy, allergic diseases, allergic rhinitis, hay fever.
For citation: Chotchaeva A.A., Kolotilina A.I., Korsunskiy I.A. et al. Allergic rhinitis: approaches to diagnostics and management // RMJ. 2018. № 9. P. 22–28.